62° Clear

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

132.28 +1.41 (+1.08%)

Streaming Delayed Price Updated: 3:43 PM EDT, Jun 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Repligen Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Evaluating Repligen: Insights From 6 Financial Analysts ↗

September 26, 2024

Via Benzinga

Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday? ↗

August 16, 2024

Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York.

Via Benzinga

Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio? ↗

August 04, 2024

Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio!

Via Benzinga

Here's Why Shares in This Hot Healthcare Stock Surged This Week ↗

August 02, 2024

The bioprocessing market is preparing for a recovery.

Via The Motley Fool

These Analysts Revise Their Forecasts On Repligen Following Q2 Results ↗

July 31, 2024

Via Benzinga

Repligen Corp. (NASDAQ: RGEN) Making Surprising Moves in Tuesday Session

April 23, 2024

Via Investor Brand Network

Earnings Scheduled For February 21, 2024 ↗

February 21, 2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

Via Benzinga

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 30, 2024

Via Benzinga

Repligen Lowers Guidance On China Weakness, Analyst Expects ↗

July 30, 2024

Repligen reports Q2 sales of $154.1 million, closely matching the consensus estimate. Adjusted gross margin fell to 49.6% from 50.2%, with an EPS of $0.33. CEO Tony J. Hunt highlights strong Pharma...

Via Benzinga

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday ↗

July 30, 2024

Via Benzinga

Analyst Ratings For Repligen ↗

December 20, 2023

Via Benzinga

This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

June 26, 2024

Via Benzinga

NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

June 26, 2024

Via Benzinga

Top 3 Health Care Stocks That Could Blast Off In June ↗

June 21, 2024

Via Benzinga

Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 13, 2024

Via Benzinga

The Latest Analyst Ratings for Repligen ↗

December 04, 2023

Via Benzinga

Analyst Expectations for Repligen's Future ↗

November 02, 2023

Via Benzinga

RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024 ↗

May 01, 2024

RGEN stock results show that Repligen missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday ↗

April 23, 2024

Via Benzinga

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday ↗

March 25, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Via Benzinga

Topics Stocks

What's Going On With Life Science-Focused Repligen Stock Today? ↗

February 21, 2024

Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new modalities; 2024 revenue forecast: $620-$650 million.

Via Benzinga

Keybanc Maintains Overweight Rating for Repligen: Here's What You Need To Know ↗

November 01, 2023

Via Benzinga

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 26, 2024

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

Via Benzinga

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday ↗

January 26, 2024

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

Via Benzinga

Topics Stocks

How Good Is Your Market Cap Knowledge? ↗

January 11, 2024

A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.

Via The Motley Fool

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday ↗

November 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

A New Bull Market Is Coming! 3 Stocks Set to Soar 65% to 132% Higher ↗

November 01, 2023

Wall Street has high hopes for these stocks to buy for the next bull market. Consider adding them to your portfolio.

Via InvestorPlace

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

Repligen's Strong Q3 Recovery: CEO Says Pharma Orders Rebound, Analytics Business Grows ↗

October 31, 2023

Repligen Corporation (NASDAQ: RGEN) reported third-quarter (Q3) revenues of $141.19 million, down 30% Y/Y, beating the

Via Benzinga

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Repligen Corporation - Common Stock (NQ:RGEN)

All News about Repligen Corporation - Common Stock

Sections

Services